Filippatos, Gerasimos
Filippatos, Gerasimos, 19..-...., professeur de cardiologie
Gerasimos Filippatos researcher
VIAF ID: 27146998362718940704 (Personal)
Permalink: http://viaf.org/viaf/27146998362718940704
Preferred Forms
- 100 1 _ ‡a Filippatos, Gerasimos
- 100 1 _ ‡a Filippatos, Gerasimos (sparse)
- 100 1 _ ‡a Filippatos, Gerasimos, ‡d 19..-...., ‡c professeur de cardiologie
- 100 0 _ ‡a Gerasimos Filippatos ‡c researcher
4xx's: Alternate Name Forms (2)
Works
Title | Sources |
---|---|
2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: The Task Force for diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and the European Association for the Study of Diabetes (EASD) | |
The @ESC textbook of heart failure | |
Anticoagulants, antiplatelets, and statins in heart failure | |
Atrial fibrillation in chronic non-cardiac disease : where do we stand? | |
Cachexia: common, deadly, with and urgent need for precise definition and new therapies | |
Cancer diagnosis in patients with heart failure : epidemiology, clinical implications and gaps in knowledge | |
A comprehensive characterization of acute heart failure with preserved versus mildly reduced versus reduced ejection fraction - insights from the ESC-HFA EORP Heart Failure Long-Term Registry | |
European society of cardiology heart failure long-term registry (ESC-HF-LT): 1-year follow-up outcomes and sifferences across regions | |
Evaluation of an individualized dose titration regimen of patiromer to prevent hyperkalaemia in patients with heart failure and chronic kidney disease | |
Expert consensus document on the management of hyperkalaemia in patients with cardiovascular disease treated with renin angiotensin aldosterone system inhibitors: coordinated by the Working Group on Cardiovascular Pharmacotherapy of the European Society of Cardiology | |
Gender-related variations in the natural history of chronic heart failure: a propensity-matched study | |
Implementation of guidelines improves mortality in patients admitted in community hospital for decompensated chronic heart failure | |
Intravenous ferric carboxymaltose improves quality of life in patients with chronic heart failure and iron deficiency regardless the presence of anemia : an analysis from the FAIR-HF study | |
Organ dysfunction, injury and failure in acute heart failure : from pathophysiology to diagnosis and management. | |
Relation of longitudinal changes in quality of life assessments to changes in functional capacity in patients with heart failure with and without anemia | |
Sacubitril/valsartan eligibility and outcomes in the ESC-EORP-HFA Heart Failure Long-Term Registry bridging between European Medicines Agency/Food and Drug Administration label, the PARADIGM-HF trial, ESC guidelines, and real world | |
Type 2 diabetes mellitus and heart failure : a position statement from the Heart Failure Association of the European Society of Cardiology | |
Unravelling the interplay between hyperkalaemia, renin-angiotensin-aldosterone inhibitor use and clinical outcomes : data from 9222 chronic heart failure patients of the ESC-HFA-EORP Heart Failure Long-Term Registry | |
What does the lay public know about heart failure? Findings from the Heart failure awareness day initiative |